BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25750571)

  • 21. A patient with congenital nephrogenic diabetes insipidus due to AVPR2 mutation complicated by persisting polydipsia under hemodialysis treatment.
    Iijima T; Mori T; Sohara E; Suwabe T; Hoshino J; Ubara Y
    CEN Case Rep; 2021 May; 10(2):226-229. PubMed ID: 33125666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus.
    Cheong HI; Park HW; Ha IS; Moon HN; Choi Y; Ko KW; Jun JK
    Nephron; 1997; 75(4):431-7. PubMed ID: 9127330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephrogenic diabetes insipidus due to a new mutation of the arginine vasopressin V2 receptor gene in a girl presenting with non-accidental injury.
    Chan Seem CP; Dossetor JF; Penney MD
    Ann Clin Biochem; 1999 Nov; 36 ( Pt 6)():779-82. PubMed ID: 10586320
    [No Abstract]   [Full Text] [Related]  

  • 25. Phenotype variability in nephrogenic diabetes insipidus due to p.D85N mutation in the arginine vasopressin receptor 2 gene.
    Morimoto T; Nakayama M; Fujiwara I; Kondo Y; Mugishima H; Takahashi S
    Nephrology (Carlton); 2013 May; 18(5):390-1. PubMed ID: 23600372
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus.
    Soylu A; Kasap B; Oğün N; Oztürk Y; Türkmen M; Hoefsloot L; Kavukçu S
    Pediatr Nephrol; 2005 Dec; 20(12):1814-7. PubMed ID: 16240160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrogenic diabetes insipidus: treat with caution.
    Boussemart T; Nsota J; Martin-Coignard D; Champion G
    Pediatr Nephrol; 2009 Sep; 24(9):1761-3. PubMed ID: 19373493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nephrogenic diabetes insipidus].
    Iwasaki Y; Hashimoto K
    Nihon Rinsho; 2006 May; Suppl 1():197-9. PubMed ID: 16776126
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular pathogenesis of nephrogenic diabetes insipidus.
    Nguyen MK; Nielsen S; Kurtz I
    Clin Exp Nephrol; 2003 Mar; 7(1):9-17. PubMed ID: 14586738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular biological studies on patients with nephrogenic diabetes insipidus].
    Szalai C; Molnár E; Sallay P; Czinner A
    Orv Hetil; 1998 Apr; 139(15):883-7. PubMed ID: 9579101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrogenic diabetes insipidus.
    Bockenhauer D; Bichet DG
    Curr Opin Pediatr; 2017 Apr; 29(2):199-205. PubMed ID: 28134709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nephrogenic diabetes insipidus].
    Radó J
    Orv Hetil; 1998 Mar; 139(10):559-63. PubMed ID: 9538640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mutation affecting the arginine-137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin-2.
    Hinrichs GR; Hansen LH; Nielsen MR; Fagerberg C; Dieperink H; Rittig S; Jensen BL
    Physiol Rep; 2016 Apr; 4(8):. PubMed ID: 27117808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV; Deen PM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus.
    Rocha JL; Friedman E; Boson W; Moreira A; Figueiredo B; Liberman B; de Lacerda L; Sandrini R; Graf H; Martins S; Puñales MK; De Marco L
    Hum Mutat; 1999; 14(3):233-9. PubMed ID: 10477431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasopressin receptor mutations in nephrogenic diabetes insipidus.
    Bichet DG
    Semin Nephrol; 2008 May; 28(3):245-51. PubMed ID: 18519085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Etiology and clinical characteristics of congenital nephrogenic diabetes insipidus].
    Gu F; Jin ZM; Shi YF; Deng JY
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1448-9. PubMed ID: 15500742
    [No Abstract]   [Full Text] [Related]  

  • 39. [Compound heterozygosis with novel AQP2 gene mutation in sisters affected by autosomal congenital nephrogenic diabetes insipidus].
    Musone D; Nicosia V; Treglia A; Amoroso F; de Gemmis P; Enzo MV; Hladnik U
    G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and cellular defects in nephrogenic diabetes insipidus.
    Knoers NV; van Os CH
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):353-8. PubMed ID: 8823534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.